Skip to main content

Corning wins U.S. funding to boost glass vial manufacturing for COVID-19 therapies

Corning Inc said on Tuesday it would receive $204 million from the U.S. government to boost the manufacturing capacity of its glass vials after the company was selected as a packaging provider for COVID-19 vaccines and treatments.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.